We use cookies to make this site as useful as possible. By continuing browsing we assume that you agree to accept cookies in accordance with our cookie policy.
To find out more or to change your cookie settings at any time, see our cookie policy. OK

  • About
  • Careers
  • Select Dechra business
    • Dechra Pharmaceuticals PLC
    • Dechra Manufacturing
  • Sign in
  • Select country
    • Danmark
    • Suomi
    • France
    • Deutschland
    • Österreich
    • Nederland
    • Norge
    • Ireland
    • Italia
    • España
    • Portugal
    • Sverige
    • United Kingdom
    • België
    • USA
    • Canada
    • Polska
    • Hrvatska
    • Bosna i Hercegovina
    • Slovenija
    • Australia
    • México
    • Global
    • By clicking a flag you will be leaving this country website to access another site in the Dechra group not applicable to your territory and which may have different legislation
Dechra Veterinary Products
Your materials (0)
  • Products
  • Therapy Areas
  • Academy
  • News
  • Events
  • Support Materials
  • Contact
  • Your materials (0)
  • You are here:
  • Home
  • Back
  • You are here:
  • Osurnia

DISCLAIMER

The content on this page is provided for veterinary professionals.

By clicking on 'OK', you confirm that you are a veterinary professional.

Cancel

We know that Otitis externa is a common challenge in practice, with ear infections among the most frequent reasons for dogs to present in the clinic2. Cases can be challenging and sometimes frustrating.

Choosing a gel treatment that acts where it’s needed supports a successful outcome for otitis externa* cases.

Patented gel formulation

Osurnia has been uniquely designed so it is less likely to be dislodged from the ear.  It’s easily administered, adaptable gel formulation squeezes out of the tube and applies like a liquid, spreading through the ear canal. It then forms as a gel, coating the ear lining prolonging contact of the active ingredients at the site of infection1,  helping to reduce treatment frequency and minimise treatment uncertainty.

Gentle application for dogs with painful ears

Osurnia comes in a pre-measured, single-dose tube, with a flexible soft tip making sure the dog gets the right dose every time, while minimising discomfort.

Your browser does not support the video tag.

Osurnia brings the owner back to your clinic

Successful management of otitis externa can often involve long term, or even lifelong treatment of the underlying causes which requires a high level of owner commitment and a good relationship between you and the owner.

When it comes to otitis externa* treatment, Osurnia gives an extra dose of reassurance.

Osurnia’s treatment regime allows you to take control and improve compliance.

It’s second application:

  • Provides an opportunity to check the dog mid-treatment
  • Ensure it’s responding as planned
  • Brings the pet owner back to the clinic

This helps build trust and strengthen the relationship.

Product information

Request a sales
call

Order now

 

Support materials

Pet owner reminder card

Pet owner leaflet

Dechra has a range of products to support you in the treatment and long-term management of otitis. Within our range we are able to offer you a suitable treatment for the pet taking into consideration your clinical preference and the owners lifestyle.  

 

Find out more about our Otitis range

Supporting you with individual cases

Dedicated Technical Support

Tel: 01939 211200 (option 1)
Email: technical@dechra.com

 

Contact us

Upcoming CPD Events

References

* For the treatment of acute otitis externa and acute exacerbation of recurrent otitis externa associated with Staphylococcus pseudintermedius and Malassezia pachydermatis in dogs.

  1. T. Nuttall and S. Forster (2015) Terbinafine and florfenicol concentrations in the canine ear exceed minimum inhibitory concentrations for common otic pathogens after treatments with Osurnia® . Proceedings of the British Veterinary Dermatology Study Group, April, Birmingham, UK, pp91-94T
  2. O’Neill et al (2014) Prevalence of disorders recorded in dogs attending primary-care veterinary practices in England. PLoS ONE 9(3) e90501
 
 
 
 
 
 
 
 
 
 
 
 
Website: Co3
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Sitemap
  • Select Dechra business
    • Dechra Pharmaceuticals PLC
    • Dechra Manufacturing

Sign in

Sign in

Help: Forgot password?

 Don't have a Dechra UK Website account?

It is free and only takes a few minutes - Sign up today ensuring you are on your local country site first.

Register here